Abstract
Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFRspecific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumor-cell killing. These results suggest that the predominant mode of action of EGFR-targeting antibodies depend on EGFR expression levels. © 2013 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
Derer, S., Lohse, S., & Valerius, T. (2013). EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies. OncoImmunology, 2(5). https://doi.org/10.4161/onci.24052
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.